Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
ASCRS Subspecialty Day will feature full-day programming in the areas of cornea, glaucoma, and refractive surgery. New this year, registrants of Subspecialty Day will also be able to attend the inaugural Digital Day program, taking place in conjunction with ASCRS Subspecialty Day and sponsored by the Digital Ophthalmic Society.
Cornea Editor Julie Schallhorn, MD, discusses the importance of the in-person education that physicians will find at the ASCRS Annual Meeting and previews the articles in the Cornea section of the issue.
➤ Patient enrollment complete for sustained release AMD therapy trial ➤ First patient dosed with corneal endothelial cell substitute ➤ First patient dosed in RNAi therapy for wet and dry AMD ➤ Study: early signs of corneal graft rejection reversed with steroid nanoparticle ➤ Company announces anti-VEGF market tracker ➤ ASCRS news and events
➤ ASCRS EyeWorld Weekly: View the current issue ➤ Allogenic cell therapy receives regulatory approval for bullous keratopathy indication ➤ 24-month data on AMD photobiomodulation therapy ➤ Patient enrollment complete for Phase 3 trial evaluating topical presbyopia treatment ➤ Pre-IND meeting for treatment of corneal endothelial disease ➤ IND submitted for geographic atrophy treatment ➤ Second Phase 3 trial for dry eye disease therapy ➤ ASCRS news and events
Bala Ambati, MD, won The Winning Pitch Challenge during the session at the ASCRS Annual Meeting in 2019. His company, iVeena, presented the IVMED-80, a pharmacologic drop treatment for keratoconus.
At The Winning Pitch Challenge in 2020, the top prize went to Sunil Shah, MD, presenting on Photon Therapeutics and its device for ultraviolet light treatment for corneal infections. Simon Dean, MBChB, MSc, spoke with EyeWorld about the company’s technology and updates since winning the competition.
➤ Alert: eye infections linked to artificial tear ➤ Phase 2 data from research targeting Sjogren’s treatment ➤ First patient dosed in Phase 1 study for epithelial defect treatment ➤ Study compares DMEK tissue preparation techniques ➤ Topline results from oral diabetic retinopathy treatment trial ➤ ASCRS news and events
The use of autologous blood eye drops continues to be a point of interest in research and as a potential cost-effective alternative to processed hemoderivatives. A recent study published in the journal Clinical Ophthalmology continues to advance the topic.
➤ Clinical trial for new cataract surgery technology ➤ Topline results from Phase 2 trial investigating treatment for persistent corneal epithelial defect ➤ Update on sustained-release glaucoma implant and Glaukos cornea programs ➤ First patient enrolled in Phase 3 trial for presbyopia drop ➤ ASCRS news and events
➤ FDA approves NDA for IOP-lowering drug ➤ NDA submitted for presbyopia drop ➤ IND accepted for investigational treatment of persistent corneal epithelial defect ➤ Topline results from Phase 2 study of novel sedation drug for cataract surgery ➤ First patient enrolled in Phase 3 trial for investigational TED therapy ➤ Complimentary access to video journal ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.